NSC12 is primarily used in research settings as a small molecule inhibitor that targets specific cellular pathways involved in inflammation and cancer progression. It has shown potential in modulating protein-protein interactions that are critical for the activation of inflammatory responses, making it a useful tool in studying conditions like sepsis and autoimmune diseases. In oncology research, NSC12 demonstrates activity by interfering with tumor cell signaling, particularly through the inhibition of growth factor binding, which can suppress tumor proliferation and metastasis in preclinical models. Due to its ability to cross cell membranes effectively, NSC12 is also employed in cellular uptake studies and as a scaffold for developing more potent analogs. Its application remains largely confined to laboratory investigations, where it aids in validating therapeutic targets and understanding disease mechanisms.